1 – 4 of 4
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Economic Burden of Parkinson’s Disease : A Multinational, Real-World, Cost-of-Illness Study
Chaudhuri, K. Ray ; Azulay, Jean Philippe ; Odin, Per LU
; Lindvall, Susanna
; Domingos, Josefa
; Alobaidi, Ali
; Kandukuri, Prasanna L.
; Chaudhari, Vivek S.
; Parra, Juan Carlos
and Yamazaki, Toru
, et al.
(2024)
In Drugs - Real World Outcomes
11(1).
p.1-11
- Contribution to journal › Article
- 2022
-
Mark
Comparative Effectiveness of Device-Aided Therapies on Quality of Life and Off-Time in Advanced Parkinson’s Disease : A Systematic Review and Bayesian Network Meta-analysis
Antonini, Angelo ; Pahwa, Rajesh ; Odin, Per LU
; Isaacson, Stuart H.
; Merola, Aristide
; Wang, Lin
; Kandukuri, Prasanna L.
; Alobaidi, Ali
; Yan, Connie H.
and Bao, Yanjun
, et al.
(2022)
In CNS Drugs
36(12).
p.1269-1283
- Contribution to journal › Scientific review
-
Mark
Psychometric Properties of Clinical Indicators for Identification and Management of Advanced Parkinson’s Disease : Real-World Evidence From G7 Countries
Antonini, Angelo ; Pahwa, Rajesh ; Odin, Per LU
; Henriksen, Tove
; Soileau, Michael J.
; Rodriguez-Cruz, Ramon
; Isaacson, Stuart H.
; Merola, Aristide
; Lindvall, Susanna
and Domingos, Josefa
, et al.
(2022)
In Neurology and Therapy
11(1).
p.303-318
- Contribution to journal › Article
-
Mark
Does the 5–2-1 criteria identify patients with advanced Parkinson's disease? Real-world screening accuracy and burden of 5–2-1-positive patients in 7 countries
Malaty, Irene A. ; Martinez-Martin, Pablo ; Chaudhuri, K. Ray ; Odin, Per LU
; Skorvanek, Matej
; Jimenez-Shahed, Joohi
; Soileau, Michael J.
; Lindvall, Susanna
; Domingos, Josefa
and Jones, Sarah
, et al.
(2022)
In BMC Neurology
22(1).
- Contribution to journal › Article